Last reviewed · How we verify

NCT04163965: HSM-cECG

Data Collection for Pacemaker Recognition Through Capacitive ECG

Completed NA Last updated 11 March 2020
What this trial tests

NA trial testing Capacitive ECG in Pacemaker DDD in 20 participants. Completed in 13 February 2020.

Timeline
13 November 2019
Primary endpoint
28 November 2019
13 February 2020

Quick facts

Lead sponsorRWTH Aachen University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposebasic science
Enrollment20
Start date13 November 2019
Primary completion28 November 2019
Estimated completion13 February 2020
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

RWTH Aachen University

Who can join

60 and older, any sex, with Pacemaker DDD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the signal quality of capacitive ECG (cECG) on pacemaker patients and whether paced rhythms of the pacemaker can be distinguished from the normal beats using cECG signals.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Car Seats with Capacitive ECG Electrodes Can Detect Cardiac Pacemaker Spikes.
    Uguz DU, Dettori R, Napp A, Walter M, et al · · 2020 · cited 11× · PMID 33158273 · DOI 10.3390/s20216288

Verify or expand the search:

Other recruiting trials for Pacemaker DDD

Currently open trials in the same condition.

Other RWTH Aachen University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04163965.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing